AIOLOS BIO LIMITED - Profile & Financials

Accounts Submitted 22 May 2025

Confirmation Statement Submitted 30 Jul 2025

Net assets £556.98K £850.17K 2024 year on year

Total assets £556.98K £157.57K 2024 year on year

Total Liabilities £0.00 £1.01M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover AIOLOS BIO LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£556.95k

Increased by £381.46k (+217%)

Net Assets

£556.98k

Increased by £850.17k (+290%)

Total Liabilities

N/A

Decreased by £1.01M (-100%)

Turnover

£16.73M

Increased by £12.80M (+326%)

Employees

N/A

Decreased by 10 (-100%)

Debt Ratio

N/A

Decreased by 141 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 2 resigned

Show resigned officers

						Status
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	14 Feb 2024	Active
Peter Kenneth Hopkins	Director	British	United Kingdom	53	14 Feb 2024	Active

Shareholders

Shareholders (2)


Aiolos Bio, Inc.	100.0%	100	Ordinary	17 Jul 2024
One Bio, Inc	0.0%	0	Ordinary	17 Jul 2024

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Gsk Finance (no 2) Limited

United Kingdom

Active

Notified 14 Feb 2024

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent

See All Controllers

Group Structure

GSK FINANCE (NO 2) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

AIOLOS BIO LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
30 Jul 2025	Confirmation Statement	Confirmation statement made on 2025-07-30 with no updates	View(3 pages)
30 Jun 2025	Confirmation Statement	Confirmation statement made on 2025-06-30 with no updates	View(3 pages)
22 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(17 pages)
23 Sept 2024	Officers	Change to director Dr Peter Kenneth Hopkins on 2024-09-11	View(2 pages)
22 Sept 2024	Accounts	Annual accounts made up to 2023-12-31	View(16 pages)